Difficulty: Medium
Average Score: 76%
Practice
Levodopa should not be given to patients taking:
Correct answer
B
Rationale
The correct answer is B: Monoamine oxidase A inhibitors. Levodopa should not be given concurrently with MAO-A inhibitors as they can potentiate the effects of levodopa, leading to an increased risk of hypertensive crisis. MAO-A inhibitors inhibit the breakdown of levodopa, causing an accumulation of dopamine in the brain. This combination can result in severe hypertension and other adverse effects.
Choice A (Bromocriptine) is incorrect because it is a dopamine agonist that can be used in combination with levodopa for Parkinson's disease treatment. Choice C (Carbidopa) is incorrect because it is often given in combination with levodopa to enhance its effectiveness by preventing its peripheral metabolism. Choice D (Nonselective beta-adrenergic antagonists) is incorrect as they do not have a direct interaction with levodopa.
Choice A (Bromocriptine) is incorrect because it is a dopamine agonist that can be used in combination with levodopa for Parkinson's disease treatment. Choice C (Carbidopa) is incorrect because it is often given in combination with levodopa to enhance its effectiveness by preventing its peripheral metabolism. Choice D (Nonselective beta-adrenergic antagonists) is incorrect as they do not have a direct interaction with levodopa.